Customer Login
Thomson Reuters Cortellis™ for Clinical Trials Intelligence provides you with the information needed to evaluate market opportunities, identify potential barriers, and make better informed decisions regarding clinical trial design and operations.

Cortellis™ for Clinical Trials Intelligence includes global clinical trial protocols and outcomes for drugs, medical devices and biomarkers expertly uncovered and unified from a variety of data sources. It integrates with other key intelligence areas from Thomson Reuters including drug pipeline, deals, and patents to provide unique insights that support a wide variety of strategic decision making.

Cortellis Scuba Diver
The Cortellis web portal will enhance your interrogation of clinical trial information with robust searching, alerting, and exporting capabilities. Additional delivery options include dynamic real-time visualizations, access to data via APIs, and integration with your existing knowledge platforms and workflow solutions.

With Thomson Reuters Cortellis™ for Clinical Trials Intelligence, you can answer questions like:
  • What are the competitive opportunities and associated barriers for a given drug based on clinical trial data?
  • Which trials will I compete against for recruitment?
  • What is the patient demand by country and patient segment?
  • What trial design will increase likelihood of approval while speeding trial execution?
  • Who are my competitors and what are they doing?
  • Which messages, based on clinical trial data, will bolster my market position against my competition?
  • Where can I find licensing/collaboration opportunities?

For more information
For more information, or to discuss a project, contact your Thomson Reuters representative, or email us at

© Thomson Reuters – All rights resevered.

Follow @cortellis